1 - 15 of 152 Results Clear All
We must come together, setting politics aside, if we want to beat the COVID-19 pandemic
Gladstone Experts COVID-19 Virology Greene Lab Ott Lab
San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, comments on the lack of data impeding efforts to understand the spread of the coronavirus in California, and the necessity to wear masks.
Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab
KQED—Mauricio Montano, director of Gladstone's new BSL-3 lab, and Melanie Ott, director of the Gladstone Institute of Virology, explain how scientists will use the high-level biosafety lab for COVID-19 research, and how they must gear up before getting in the door.
Gladstone Experts COVID-19 Virology Greene Lab Ott Lab
San Francisco Business Times—Ten years ago, an international HIV study led by then Gladstone Investigator Robert Grant, MD, MPH, showed that the antiretroviral drug Truvada taken as a prophylactic could reduce the risk of infection by HIV, a study that was declared medical breakthrough of the year by Time magazine.
Gladstone Experts HIV/AIDS
The Wall Street Journal—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, stresses wearing a mask as one of the most important things people can do right now to bring the spread of the coronavirus under control.
Gladstone Experts COVID-19 Virology Ott Lab
Labiotech.eu—Senior Investigator Warner Greene, MD, PhD, comments on the use of interferons as therapeutic intervention in the early stages of COVID-19.
Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab
With a tool capable of taking large sets of data and distilling it into patterns, researchers at Gladstone hope to better predict COVID-19 patient outcomes and improve patient care.
Gladstone Experts COVID-19 Data Science and Biotechnology Virology Greene Lab Pollard Lab AI Big Data
KNX 1070—Senior Investigator Warner Greene, MD, PhD, comments on the recent findings that antibodies against SARS-CoV-2, the cause of COVID-19, disappear quickly from people's blood after they recover from infection, and discusses the implications for vaccine development.
Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab
Drug Target Review—Senior Investigator Katerina Akassoglou, PhD, explains her team’s recent discovery of the immune cells in the brain that promote neurodegeneration in diseases such as multiple sclerosis and Alzheimer’s disease.
Gladstone Experts Multiple Sclerosis Neurological Disease Akassoglou Lab
NBC Bay Area—Senior Investigator Warner Greene, MD, PhD, gives advice on how to protect kids from COVID-19 and train them to practice good hygiene in preparation for back-to-school.
Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab
San Francisco Chronicle—Commenting on the disappointing recent reports about antibodies as barriers against coronavirus infection, Senior Investigator Nevan Krogan, PhD, and Visiting Scientist Danielle Swaney, PhD, emphasize the need for drug treatments as an alternative, and describe how they look for such treatments.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab
Live Science—Senior Investigator Warner Greene, MD, PhD, lends his expertise in immunology to a detailed article describing the various types of antibodies the immune system produces during an infection, and how they help fight invaders or can be used as therapies.
Gladstone Experts COVID-19 Autoimmune Diseases Center for HIV Cure Research Greene Lab
San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, blames the easing of restrictions in the spring on the recent uptick in COVID-19 confirmed cases, hospitalizations, and deaths in many California counties.
Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab
San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, explains that just like with HIV/AIDS, combination drug therapy might offer a reasonable option to protect against COVID-19 until good vaccines come along.
Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab
considerable.—Senior Investigator Nevan Krogan, PhD, recounts his team's recent finding that drugs that target enzymes known as kinases, many of which were developed to fight cancer, could be effective against COVID-19.
Gladstone Experts COVID-19 Data Science and Biotechnology Krogan Lab